Systems Biology of Vascular Endothelial Growth Factors

被引:112
作者
Gabhann, Feilim Mac [1 ,2 ]
Popel, Aleksander S. [3 ]
机构
[1] Univ Virginia, Dept Biomed Engn, Charlottesville, VA 22908 USA
[2] Univ Virginia, Robert M Berne Cardiovasc Res Ctr, Charlottesville, VA 22908 USA
[3] Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21205 USA
基金
美国国家卫生研究院;
关键词
D O I
10.1080/10739680802095964
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Several cytokine families have roles in the development, maintenance, and remodeling of the microcirculation. Of these, the vascular endothelial growth factor (VEGF) family is one of the best studied and one of the most complex. Five VEGF ligand genes and five cell-surface receptor genes are known in the human, and each of these may be transcribed as multiple splice isoforms to generate an extensive family of proteins, many of which are subject to further proteolytic processing. Using the VEGF family as an example, we describe the current knowledge of growth-factor expression, processing, and transport in vivo. Experimental studies and computational simulations are being used to measure and predict the activity of these molecules, and we describe avenues of research that seek to fill the remaining gaps in our understanding of VEGF family behavior.
引用
收藏
页码:715 / 738
页数:24
相关论文
共 179 条
[71]   Distinct modes of collagen type I proteolysis by matrix metalloproteinase (MMP) 2 and membrane type I MMP during the migration of a tip endothelial cell: Insights from a computational model [J].
Karagiannis, ED ;
Popel, AS .
JOURNAL OF THEORETICAL BIOLOGY, 2006, 238 (01) :124-145
[72]   A theoretical model of type I collagen proteolysis by matrix metalloproteinase (MMP) 2 and membrane type 1 MMP in the presence of tissue inhibitor of metalloproteinase 2 [J].
Karagiannis, ED ;
Popel, AS .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (37) :39105-39114
[73]   Regulation of vascular endothelial growth factor expression in human gastric cancer cells by interleukin-1β [J].
Kawaguchi, M ;
Akagi, M ;
Gray, MJ ;
Liu, WB ;
Fan, F ;
Ellis, LM .
SURGERY, 2004, 136 (03) :686-692
[74]   INHIBITION OF VASCULAR ENDOTHELIAL-CELL GROWTH-FACTOR ACTIVITY BY AN ENDOGENOUSLY ENCODED SOLUBLE RECEPTOR [J].
KENDALL, RL ;
THOMAS, KA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (22) :10705-10709
[75]   Identification of a natural soluble form of the vascular endothelial growth factor receptor, FLT-1, and its heterodimerization with KDR [J].
Kendall, RL ;
Wang, G ;
Thomas, KA .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1996, 226 (02) :324-328
[76]   The carboxyl-terminal domain (111-165) of vascular endothelial growth factor is critical for its mitogenic potency [J].
Keyt, BA ;
Berleau, LT ;
Nguyen, HV ;
Chen, H ;
Heinsohn, H ;
Vandlen, R ;
Ferrara, N .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (13) :7788-7795
[77]   Using process diagrams for the graphical representation of biological networks [J].
Kitano, H ;
Funahashi, A ;
Matsuoka, Y ;
Oda, K .
NATURE BIOTECHNOLOGY, 2005, 23 (08) :961-966
[78]   Scaffolding protein Grb2-associated binder 1 sustains epidermal growth factor-induced mitogenic and survival signaling by multiple positive feedback loops [J].
Kiyatkin, Anatoly ;
Aksamitiene, Edita ;
Markevich, Nick I. ;
Borisov, Nikolay M. ;
Hoek, Jan B. ;
Kholodenko, Boris N. .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (29) :19925-19938
[79]   Properties of switch-like bioregulatory networks studied by simulation of the hypoxia response control system [J].
Kohn, KW ;
Riss, J ;
Aprelikova, O ;
Weinstein, JN ;
Pommier, Y ;
Barrett, JC .
MOLECULAR BIOLOGY OF THE CELL, 2004, 15 (07) :3042-3052
[80]   Neuropilin is a Semaphorin III receptor [J].
Kolodkin, AL ;
Levengood, DV ;
Rowe, EG ;
Tai, YT ;
Giger, RJ ;
Ginty, DD .
CELL, 1997, 90 (04) :753-762